[Lyell's syndrome and its ophthalmologic manifestations in Cameroon]
- PMID: 10740048
[Lyell's syndrome and its ophthalmologic manifestations in Cameroon]
Abstract
Background: To study basic epidemiological datas and ocular involvment during toxic epidermal necrolysis (T.E.N.) in Cameroonian patients.
Methods: Ten consecutive patients in the Central Hospital of Yaounde were included during a 4 years period. Anamnesis, clinical features, dermatological, ophthalmological and pathological examinations were done. Minimal follow up of 3 months.
Results: Mean age: 20.1 +/- 11.4 yrs (SD); culprit drugs: sulfadoxin (5/10), sulfamethoxazol (3/10); phenytoin (1/10). Mean of skin detachment: 41 +/- 17%. 2 patients died with sulfadoxin as culprit drug. Early ocular findings: conjunctivitis (all patients), symblepharon (1/8), ankyloblepharon (3 patients over 8 with sulfadoxin as culprit drug). All cases with ankyloblepharon (3) evoluated toward formation of a fibrovascular precorneal membrane with blindness. Two of the patients received a kerothoprosthesis on one eye. The 3 patients had a severe dry eye syndrome.
Conclusion: TEN appears to be uncommon in Cameroon. Use of sulfonamides for treatment and prevention of malaria and AID'S opportunistic infections may increase the incidence of disease in tropical african areas. Ophthalmologists should be aware of early management of ocular manifestations in Lyell syndrome to avoid severe sequelae. That sequelae may be due to usual intensive healing in African patients. Severe corneal damages can be corrected only by keratoprosthesis.
Similar articles
-
[Ocular manifestations and sequelae of Lyell syndrome caused by sulfadoxine-pyrimethamine in Cameroon].J Fr Ophtalmol. 1998 Jan;21(1):72-7. J Fr Ophtalmol. 1998. PMID: 9834901 French.
-
The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome).Arch Dermatol. 1987 Sep;123(9):1166-70. Arch Dermatol. 1987. PMID: 3632001
-
[Ocular complications of Lyell's syndrome: recent concepts apropos of 26 cases].J Fr Ophtalmol. 1985;8(3):239-43. J Fr Ophtalmol. 1985. PMID: 4056315 French.
-
High-dose intravenous immunoglobulin in the treatment of toxic epidermal necrolysis: a study of ocular benefits.Eye (Lond). 2005 Aug;19(8):846-53. doi: 10.1038/sj.eye.6701653. Eye (Lond). 2005. PMID: 15389280 Review.
-
[Drugs involved in toxic epidermal necrolysis (Lyell's syndrome)].Therapie. 1993 Mar-Apr;48(2):133-9. Therapie. 1993. PMID: 8351682 Review. French.
Cited by
-
Prise en Charge du Syndrome de Lyell ou Necrolyse Epidermique Toxique.Ann Burns Fire Disasters. 2009 Sep 30;22(3):142-6. Ann Burns Fire Disasters. 2009. PMID: 21991170 Free PMC article. French.